These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 29873573)

  • 21. Trajectories of Metabolic Risk Factors and Biochemical Markers prior to the Onset of Cardiovascular Disease - The Doetinchem Cohort Study.
    Hulsegge G; Spijkerman AM; van der Schouw YT; Bakker SJ; Gansevoort RT; Smit HA; Verschuren WM
    PLoS One; 2016; 11(5):e0155978. PubMed ID: 27203599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes.
    Cha SA; Yun JS; Lim TS; Min K; Song KH; Yoo KD; Park YM; Ahn YB; Ko SH
    PLoS One; 2016; 11(10):e0164807. PubMed ID: 27741306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal Associations of High-Fructose Diet with Cardiovascular Events and Potential Risk Factors: Tehran Lipid and Glucose Study.
    Bahadoran Z; Mirmiran P; Tohidi M; Azizi F
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28825653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is fatty acid intake a predictor of arterial stiffness and blood pressure in men? Evidence from the Caerphilly Prospective Study.
    Livingstone KM; Givens DI; Cockcroft JR; Pickering JE; Lovegrove JA
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1079-85. PubMed ID: 23415455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk of cardiovascular death in relation to blood lipid composition in male inhabitants of Tyumen: results of a 12-year prospective study].
    Akimova EV; Gakova EI; Pushkarev GS; Smaznov VIu; Kaiumova MM; Gafarov VV; Kuznetsov VA
    Ter Arkh; 2012; 84(9):41-6. PubMed ID: 23091852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyslipidemic hypertension: distinctive features and cardiovascular risk in a prospective population-based study.
    Onat A; Hergenç G; Sari I; Türkmen S; Can G; Sansoy V
    Am J Hypertens; 2005 Mar; 18(3):409-16. PubMed ID: 15797662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies.
    Kunutsor SK; Bakker SJ; James RW; Dullaart RP
    Atherosclerosis; 2016 Feb; 245():143-54. PubMed ID: 26724525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.
    Bovet P; Shamlaye C; Gabriel A; Riesen W; Paccaud F
    BMC Public Health; 2006 Jan; 6():9. PubMed ID: 16423280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary vitamin A may be a cardiovascular risk factor in a Saudi population.
    Alissa EM; Bahjri SM; Al-Ama N; Ahmed WH; Starkey B; Ferns GA
    Asia Pac J Clin Nutr; 2005; 14(2):137-44. PubMed ID: 15927930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of hypercholesterolemia for cardiovascular disease and the population attributable fraction in a 24-year Japanese cohort study.
    Sugiyama D; Okamura T; Watanabe M; Higashiyama A; Okuda N; Nakamura Y; Hozawa A; Kita Y; Kadota A; Murakami Y; Miyamatsu N; Ohkubo T; Hayakawa T; Miyamoto Y; Miura K; Okayama A; Ueshima H;
    J Atheroscler Thromb; 2015; 22(1):95-107. PubMed ID: 25185893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of risk factors for cardiovascular diseases among Polish surgical patients over 65 years.
    Kołtuniuk A; Rosińczuk J
    Clin Interv Aging; 2016; 11():631-9. PubMed ID: 27257376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
    Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
    PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HA-ID study.
    de Winter CF; Bastiaanse LP; Hilgenkamp TI; Evenhuis HM; Echteld MA
    Res Dev Disabil; 2012; 33(6):1722-31. PubMed ID: 22699246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
    Hobbs T; Caso R; McMahon D; Nymark M
    Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world data to assess changes in low-density lipoprotein cholesterol and predicted cardiovascular risk after ezetimibe discontinuation post reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial.
    Bays HE; Patel MD; Mavros P; Ramey DR; Tomassini JE; Tershakovec AM; Baxter CA
    J Clin Lipidol; 2017; 11(4):929-937. PubMed ID: 28647412
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.